Study of the Therapeutic Effects of Intercessory Prayer (STEP): study design and research methods

Authors
Jeffrey A. Dusek, PhD, Jane B. Sherwood, RN, BSN, Richard Friedman, PhD, Patricia Myers, BA, Charles F. Bethea, MD, Sidney Levitsky, MD, Peter C. Hill, MD, Manoj K. Jain, MD, Stephen L. Kopecky, MD, Paul S. Mueller, MD, Peter Lam, PhD, Herbert Benson, MD, Patricia L. Hibberd, MD, PhD
Publication
American Heart Journal
143(4):577-584
Abstract

Background: The effect of intercessory prayer (IP) on outcome in cardiac cases has been evaluated previously, but results are controversial. The goals of the Study of the Therapeutic Effects of Intercessory Prayer (STEP) are to evaluate the effects of receipt of additional study IP and awareness of receipt of additional study IP on outcomes in patients undergoing coronary artery bypass graft surgery. STEP is not designed to determine whether God exists or whether God does or does not respond to IP.

Methods: STEP is a multicenter, controlled trial of 1802 patients in 6 US hospitals, randomized to 1 of 3 groups. Two groups were informed that they may or may not receive 14 consecutive days of additional IP starting the night before coronary artery bypass graft surgery; Group 1 received IP, Group 2 did not. A third group (Group 3) was informed that they would receive additional IP and did so. Three mainstream religious sites provided daily IP for patients assigned to receive IP. At each hospital, research nurses blinded to patient group assignment reviewed medical records to determine whether complications occurred, on the basis of the Society for Thoracic Surgeons definitions. A blinded nurse auditor from the Coordinating Center reviewed every study patient’s data against the medical record before release of study forms.

Results: The STEP Data and Safety Monitoring Board reviewed patient safety and outcomes in the first 900 study patients. Patients were enrolled in STEP from January 1998 to November 2000.

Related Listings
Fluid intelligence and brain functional organiz...
Authors
Tim Gard, Maxime Taquet, Rohan Dixit, Britta K. Holzel, Yves-Alexandre de Montoye, Narayan Brach, David H. Salat, Bradford C. Dickerson, Jeremy R. Gray, Sara W. Lazar
Journal
Frontiers in Aging Neuroscience
Numerous studies have documented the normal age-related decline of neural structure, function, and cognitive performance. Preliminary evidence suggests that meditation may reduce decline in specific cognitive domains and in brain structure. Here we extended this research by investigating the relation between age and fluid intelligence and resting state brain functional network architecture using graph theory, in middle-aged yoga and meditation practitioners, and matched controls. Flui […]
Meditation experience is associated with increa...
Authors
Sara W. Lazar, Catherine E. Kerr, Rachel H. Wasserman, Jeremy R. Gray, Douglas N. Greve, Michael Treadway, Metta McGarvey, Brian T. Quinn, Jeffery A. Dusek, Herbert Benson, Scott L. Rauch, Christopher I. Moore, Bruce Fischl
Journal
NeuroReport
·
Previous research indicates that long-term meditation practice is associated with altered resting electroencephalogram patterns, suggestive of long lasting changes in brain activity. We hypothesized that meditation practice might also be associated with changes in the brain's physical structure. Magnetic resonance imaging was used to assess cortical thickness in 20 participants with extensive Insight meditation experience, which involves focused attention to internal experiences. Brai […]
Nonpharmacologic Intervention for Hypertension ...
Authors
Jane Leserman, PhD, Eileen M Stuart, RN, MS, Mary E. Mamish, BA, John P. Desckro, RN, MS, Rita J. Beckman, RN, MS, Richard Friedman, PhD, Herbert Benson, MD
Journal
Journal of Cardiopulmonary Rehabilitation
We previously reported reduced blood pressure, psychological symptoms, and other cardiac risk factors in hypertensive patients who participated in a nonpharmacologic, outpatient behavioral program. The present study is a 3 to 5 year follow-up of 59 (60%) of the same patients (who served as their own controls) to assess continued efficacy of the program. At entry into the study, patients had hypertension for a median of 6 years. Therefore, it is unlikely that placebo effect could expla […]